India Ratings upgrades Strides Arcolab’s long-term rating to ‘BBB+’

27 Oct 2012 Evaluate

Credit rating agency, India Ratings & Research (India Ratings), a Fitch Group Company, has upgraded Strides Arcolab’s long-term issuer rating to ‘BBB+’ from ‘BBB-’ with stable outlook.

The upgrade reflects the agency’s expectation of a sustained improvement in the company’s financial leverage (adjusted debt / EBITDA) in the medium term.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

942.00 -8.50 (-0.89%)
05-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1568.85
Dr. Reddys Lab 6536.00
Cipla 1509.40
Zydus Lifesciences 1162.40
Lupin 1769.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.